tert-Butyl (S)-2-(quinolin-8-ylamino)-2-((3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-5H-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)acetate

Catalog No. :
ACSZXD605
CAS No. :
2769699-63-8
Molecular Formula :
C26H34N2O7
Molecular Weight :
486.57

IUPAC Name:tert-butyl (S)-2-(quinolin-8-ylamino)-2-((3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-5H-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)acetate

tert-Butyl (S)-2-(quinolin-8-ylamino)-2-((3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-5H-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (S)-2-(quinolin-8-ylamino)-2-((3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-5H-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)acetate
IUPAC Nametert-butyl (S)-2-(quinolin-8-ylamino)-2-((3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-5H-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)acetate
Molecular FormulaC26H34N2O7
Molecular Weight486.57
SMILESCC(C)(C)OC(=O)[C@@H](NC1=CC=CC2=C1N=CC=C2)[C@H]1O[C@@H]2OC(C)(C)O[C@@H]2[C@H]2OC(C)(C)O[C@H]21
InChI KeyOGXCSQYAKRVLJW-ZJJXDXEASA-N
CAS No.2769699-63-8

Synthetic Route by SureRoute

1. ACSZXD605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYIDV078 route compound structure diagram
    ACYIDV07816567-18-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSZXD605 route product structure diagram
    ACSZXD6052769699-63-8
Inquiry

2. ACSZXD605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWIJS410 route compound structure diagram
    ACWIJS410578-66-5 In Stock
  4. Then
  5. ACSZXD605 route product structure diagram
    ACSZXD6052769699-63-8
Inquiry

Comments (0)